RxDoctor Payments Data

John Thiesing, MD

Vascular & Interventional Radiology · Portland, ORNPI 1225104599

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (35.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Microvention, Inc. accounts for 77.5% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $639 and has fallen 96.1% since, to $25 in 2025. That places this record below the midpoint for vascular & interventional radiology clinicians in OR, where the typical reported total is $1,820.

$812in general payments, 2019–2025

Across 12 payments — averaging $67.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microvention, Inc.$629
  • Boston Scientific$91
  • Bard Peripheral Vascular, Inc.$40
  • Medtronic$27
  • Stryker$25

What the payments were for

  • Speaking & faculty fees$25331%
  • Travel & lodging$28735%
  • Food & beverage$27234%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$812 in reported general payments places this provider in the 30th percentile of 73 vascular & interventional radiology providers in Oregon.

See all vascular & interventional radiology providers in Oregon

Medicare billing

Part B allowed, 2024
$173,980
Medicare patients
1,633
Services billed
2,390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl13$59

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →